Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Assets
Current assets
Cash
Prepaid expenses and other assets
Cash and cash equivalents
Investments
Accounts receivable, net of allowance for expected credit loss of $3 and $0 at June 30, 2022 and December 31, 2021, respectively
Inventories, net
Insurance receivable
Prepaid expenses
Deferred costs
Prepaid inventories
Prepaid expenses and other current assets
Total current assets
Restricted cash equivalents held in Trust Account
Marketable securities held in Trust Account, at fair value
Restricted cash
Property, plant and equipment, net
Equity method investments
Operating lease right-of-use assets
Finance lease right-of-use assets
Deferred assets
Prepayment - long-term supply agreement
Insurance receivable
Other noncurrent assets
Total assets
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
Franchise tax payable
Income tax payable
Accrued expenses
Contract liabilities
Current maturities of long-term debt
Current maturities of long-term debt to related parties
Operating lease liabilities, current
Finance lease liabilities, current
Legal settlement payable
Other current liabilities
Total current liabilities
Deferred legal fees
Deferred underwriting commissions
Note payable
Long-term debt, net of current portion
Public and private placement warrants
Private placement warrants
Operating lease liabilities, net of current portion
Finance lease liabilities, net of current portion
Legal settlement payable
Total liabilities
Class A common stock, $0.0001 par value; 22,073,865 and 22,061,272 shares subject to possible redemption at $10 per share at September 30, 2020 and December 31, 2019 respectively
Class A common stock
Total class A common stock, $0.0001 par value; 22,073,865 and 22,061,272 shares subject to possible redemption at $10 per share at September 30, 2020 and December 31, 2019 respectively
Stockholders’ equity
Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding at December 31, 2021 and December 31, 2020)
Notes receivable from stockholders
Common stock ($0.0001 par value, 250,000,000 shares authorized, 185,811,279 and 134,458,439 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively)
Class A common stock
Class B common stock
Total common stock ($0.0001 par value, 250,000,000 shares authorized, 185,811,279 and 134,458,439 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively)
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Series Seed Preferred Stock
Class A common stock
Class B common stock
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support